Diabetes mellitus and heart failure: Epidemiology, mechanisms, and pharmacotherapy

被引:67
作者
Masoudi, Frederick A.
Inzucchi, Silvio E.
机构
[1] Univ Colorado, Dept Med, Div Cardiol, Denver Hlth Med Ctr, Denver, CO 80204 USA
[2] Univ Colorado, Dept Med, Div Cardiol, Hlth Sci Ctr, Denver, CO 80204 USA
[3] Univ Colorado, Colorado Hlth Outcomes Program, Hlth Sci Ctr, Aurora, CO USA
[4] Yale Univ, Sch Med, Dept Med, Endocrinol Sect, New Haven, CT 06510 USA
关键词
D O I
10.1016/j.amjcard.2006.11.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus and heart failure (HF), both of which are associated with high rates of adverse cardiovascular outcomes, commonly coexist. Given the marked increases in diabetes prevalence in developed countries, the proportion of the population with both conditions is likely to increase substantially. This article reviews the epidemiology of HF and diabetes, the mechanisms whereby diabetes causes HF, and the pharmacotherapy of both HF and diabetes. Specific challenges in treating patients with both HF and diabetes are also addressed. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:113B / 132B
页数:20
相关论文
共 147 条
[1]   Executive summary:: HFSA 2006 comprehensive heart failure practice guideline [J].
Adams, KF ;
Lindenfeld, J ;
Arnold, JMO ;
Baker, DW ;
Barnard, DH ;
Baughman, KL ;
Boehmer, JP ;
Deedwania, P ;
Dunbar, SB ;
Elkayam, U ;
Gheorghiade, M ;
Howlett, JG ;
Konstam, MA ;
Kronenberg, MW ;
Massie, BM ;
Mehra, MR ;
Miller, AB ;
Moser, DK ;
Patterson, JH ;
Rodeheffer, RJ ;
Sackner-Bernstein, J ;
Silver, MA ;
Starling, RC ;
Stevenson, LW ;
Wagoner, LE ;
Francis, GS ;
Bristow, MR ;
Cohn, JN ;
Colucci, WS ;
Greenberg, BH ;
Force, T ;
Krumholz, HM ;
Liu, PP ;
Mann, DL ;
Piña, IL ;
Pressler, SJ ;
Sabbah, HN ;
Yancy, CW .
JOURNAL OF CARDIAC FAILURE, 2006, 12 (01) :10-38
[2]   Type 2 diabetes, insulin secretion and β-cell mass [J].
Ahrén, B .
CURRENT MOLECULAR MEDICINE, 2005, 5 (03) :275-286
[3]  
Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4
[4]  
*AM HEART ASS, 2003, HEART STROK STAT 200
[5]   THE EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ZOFENOPRIL ON MORTALITY AND MORBIDITY AFTER ANTERIOR MYOCARDIAL-INFARCTION [J].
AMBROSIONI, E ;
BORGHI, C ;
MAGNANI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02) :80-85
[6]   HYPERINSULINEMIA PRODUCES BOTH SYMPATHETIC NEURAL ACTIVATION AND VASODILATION IN NORMAL HUMANS [J].
ANDERSON, EA ;
HOFFMAN, RP ;
BALON, TW ;
SINKEY, CA ;
MARK, AL .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2246-2252
[7]  
[Anonymous], ACT PIOGL HYDR TABL
[8]   Insulin resistance in type 2 diabetes - Role of the adipokines [J].
Arner, P .
CURRENT MOLECULAR MEDICINE, 2005, 5 (03) :333-339
[9]   Effects of sulfonylurea hypoglycemic agents and adenosine triphosphate dependent potassium channel antagonists on ventricular arrhythmias in patients with decompensated heart failure [J].
Aronson, D ;
Mittleman, MA ;
Burger, AJ .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (05) :1254-+
[10]   Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial [J].
Bakris, GL ;
Fonseca, V ;
Katholi, RE ;
McGill, JB ;
Messerli, FH ;
Phillips, RA ;
Raskin, P ;
Wright, JT ;
Oakes, R ;
Lukas, MA ;
Anderson, KM ;
Bell, DSH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (18) :2227-2236